Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Neurobiol Dis. 2019 Jan 30;125:115–122. doi: 10.1016/j.nbd.2019.01.012

Fig 2. Muscarinic antagonists increase DA release.

Fig 2.

(A) Dose response curves of the effect of THP on DA release. THP dose-dependently increased DA release in WT and Dyt1 mice, but was less effective in Dyt1 (WT n=6; Dyt1 n=6). (B). Dose response curves of the effect of atropine, a prototypical mAChR antagonist, on DA release. Atropine significantly increased DA release, but was significantly less effective in Dyt1 mice (WT n=5; Dyt1 n=5). (C) Effect of L-DOPA on DA release. L-DOPA administration had no effect on DA release in Dyt1 or control mice (WT=4; Dyt1=4). Values are normalized to untreated for each genotype and represent mean ± SEM.